An advanced intelligence engine designed to model how a drug will perform in HUMAN TRIALS so that biopharmaceutical companies can make early rapid informed decisions.
Simulations can be done EARLY and are agnostic to drug and receptor type.
Artificial Intelligence interprets the mathematical output into a biological context that clients can use instantly.
An average simulation takes 8 minutes. Full analysis and reports are available to clients in less than 1 hour.
JupitR is able to work with any ligand .sdf file (2D or 3D) or even parse from SMILES / InCHIKey
JupitR uses curated receptor batches to simulate a continuous quantum field system
JupitR enriches all uploaded data via OmnigeniQ’s
proprietary quantum biophysics protocol
Please reach us at info@omnigeniq.com if you cannot find an answer to your question.
JupitR predicts whether drug candidates will succeed or fail in human trials by simulating how molecules interact with human biology—capturing quantum charge redistribution, receptor harmonics, solvent behavior, and aggregation risk that traditional docking and AI methods miss
Yes. JupitR is operational and has already been used to analyze many drug. It runs via custom code modules and validated ligand–receptor datasets
Biopharma, biotech, and translational researchers looking to prioritize clinical candidates, reduce late-stage attrition, and flag off-target risks early.
Future versions will expand into companion diagnostics, synthetic pathway prediction, and biomarker stratification to support full pipeline decision-making
It calculates receptor–ligand field harmonics using the Hadron UVE engine: a physics-based model that runs a fixed sequence of quantum and biophysical corrections to simulate biologically relevant outcomes
Because JupitR is built from a proprietary field-theoretic approach—focused on waveform collapse- not traditional docking or black-box machine learning. It integrates physics, biology, and chemistry in a unique locked-sequence engine
AI often learns statistical correlations. JupitR simulates mechanistic causation. Where AI may guess, JupitR models how and why biological effects occur, using deterministic or adaptive UVE scoring modes
Yes. The UVE framework, harmonic scoring logic, and the receptor prioritization algorithm are protected via trade secrets and controlled dissemination. Future filings may include patents on derivative modules.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.